HYFM:NASDAQHydrofarm Holdings Group, Inc. Analysis
Data as of 2026-08-01 - not real-time
$0.54
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Hydrofarm Holdings is trading well below its short‑term and intermediate moving averages, with a relative strength index signaling oversold conditions. The price sits near a key support level while facing a clear resistance ceiling, and technical momentum indicators such as MACD are in bearish alignment, suggesting further downside pressure in the near term.
Fundamentally, the company reports negative earnings, margins and book value, and carries a substantial debt load relative to its tiny market capitalization. Cash flow is negative from operations but a modest free‑cash‑flow figure provides a thin cushion. The discounted cash flow model implies a fair value far above the current price, yet the severe profitability issues and high volatility make any upside highly speculative.
Fundamentally, the company reports negative earnings, margins and book value, and carries a substantial debt load relative to its tiny market capitalization. Cash flow is negative from operations but a modest free‑cash‑flow figure provides a thin cushion. The discounted cash flow model implies a fair value far above the current price, yet the severe profitability issues and high volatility make any upside highly speculative.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- price below short‑term and intermediate moving averages
- bearish MACD and low RSI indicating continued weakness
- negative earnings and operating cash flow
Medium Term
1–3 yearsCautious
Model confidence: 6/10
Key Factors
- persistent negative margins and high debt burden
- limited liquidity and high volatility
- lack of dividend or earnings recovery signals
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- DCF suggests substantial upside if turnaround occurs
- potential growth in controlled‑environment agriculture market
- significant execution risk given current financial distress
Key Metrics & Analysis
Financial Health
Revenue Growth-29.60%
Profit Margin-237.25%
P/E Ratio-0.9
ROE-440.05%
ROA-9.55%
P/B Ratio-0.0
Op. Cash Flow$-3055000
Free Cash Flow$16.0M
Industry P/E30.9
Technical Analysis
TrendBearish
RSI27.8
Support$0.50
Resistance$0.93
MA 20$0.70
MA 50$0.83
MA 200$1.39
MACDBearish
VolumeIncreasing
Fear & Greed Index92.88
Valuation
Fair Value$10.48
GradeUndervalued
TypeValue
Risk Assessment
Beta0.99
Volatility93.01%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.